Goldman Sachs downgraded Generali (ARZGY) to Neutral from Buy with an unchanged price target of EUR 31. The firm cites valuation for the downgrade. It sees a more in-line relative valuation for Generali after the recent rally and no clear upside to consensus expectations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARZGY:
- Generali price target raised to EUR 34.80 from EUR 30 at Berenberg
- Generali removed from European Conviction List at Goldman Sachs
- UniCredit bought less than 4% stake in Generali, Bloomberg reports
- Generali price target raised to EUR 32.67 from EUR 31.10 at Citi
- Generali price target raised to EUR 26 from EUR 22 at Deutsche Bank